Dmitry Balyasny’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Other funds holding APGE
Dmitry Balyasny's APGE Position: Q3 2026 in Review
Dmitry Balyasny sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 1,665,102 shares — an estimated $221M sold.
Dmitry Balyasny first reported a position in APGE in Q1 2024 and held it in 6 quarters. The position peaked at $221M in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.
- Dmitry Balyasny reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
- Dmitry Balyasny sold 1,665,102 Apogee Therapeutics shares in Q3 2026, an estimated $221M.
- Dmitry Balyasny first reported a position in Apogee Therapeutics in Q1 2024 and held it in 6 quarters.
- Dmitry Balyasny's Apogee Therapeutics position peaked at $221M in Q2 2026.
- 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.